Terns Pharmaceuticals, Inc.
NASDAQ:TERN
2.71 (USD) • At close April 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 161.439 | 79.926 | 143.235 | 47.699 | 74.854 | 12.327 | 82.522 |
| Short Term Investments
| 196.725 | 183.514 | 139.879 | 118.283 | 0 | 7.323 | 4.361 |
| Cash and Short Term Investments
| 358.164 | 263.44 | 283.114 | 165.982 | 74.854 | 19.65 | 86.883 |
| Net Receivables
| 0 | 0 | 0 | 0 | 12.718 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 2.966 | 0 | 0 |
| Other Current Assets
| 3.945 | 3.992 | 2.071 | 1.896 | 3.297 | 2.574 | 1.593 |
| Total Current Assets
| 362.109 | 267.432 | 285.185 | 166.93 | 90.869 | 22.224 | 88.476 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 1.47 | 1.029 | 1.804 | 1.046 | 1.175 | 0.961 | 0.261 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.35 | 0.056 | 0.037 | 0.094 | 0.246 | 0.719 | 0.335 |
| Total Non-Current Assets
| 1.82 | 1.085 | 1.841 | 1.14 | 1.421 | 1.68 | 0.596 |
| Total Assets
| 363.929 | 268.517 | 287.026 | 168.07 | 92.29 | 23.904 | 89.072 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 2.148 | 2.515 | 1.645 | 2.126 | 0.935 | 1.636 | 0.914 |
| Short Term Debt
| 0.428 | 0.603 | 1.322 | 0 | 12.88 | 0 | 0 |
| Tax Payables
| 1.49 | 1.206 | 1.071 | 0.787 | 0.657 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0.836 | 0 | 0 |
| Other Current Liabilities
| 11.584 | 7.62 | 4.43 | 3.907 | 7.513 | 3.314 | 1.461 |
| Total Current Liabilities
| 15.65 | 11.944 | 8.468 | 6.82 | 22.821 | 4.95 | 2.375 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.919 | 0 | 0.544 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0.787 | 0.657 | 0.345 | 0.142 |
| Other Non-Current Liabilities
| 1.49 | 1.206 | 1.071 | 0.947 | 0.877 | 14.402 | 14.325 |
| Total Non-Current Liabilities
| 2.409 | 1.206 | 1.615 | 0.947 | 0.877 | 14.747 | 14.467 |
| Total Liabilities
| 18.059 | 13.15 | 10.083 | 7.767 | 23.698 | 19.697 | 16.842 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 168.07 | 186.033 | 94.967 | 94.967 |
| Common Stock
| 0.009 | 0.006 | 0.005 | 0.003 | 0 | 0 | 0 |
| Retained Earnings
| -421.481 | -332.628 | -242.418 | -182.073 | -131.915 | -91.862 | -23.251 |
| Accumulated Other Comprehensive Income/Loss
| -0.279 | -0.019 | -0.822 | -0.338 | -0.124 | -0.106 | 0.059 |
| Other Total Stockholders Equity
| 767.621 | 588.008 | 520.178 | 342.711 | 14.598 | 1.208 | 0.455 |
| Total Shareholders Equity
| 345.87 | 255.367 | 276.943 | 160.303 | 68.592 | 4.207 | 72.23 |
| Total Equity
| 345.87 | 255.367 | 276.943 | 160.303 | 160.882 | 18.324 | 86.555 |
| Total Liabilities & Shareholders Equity
| 363.929 | 268.517 | 287.026 | 168.07 | 92.29 | 23.904 | 89.072 |